(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Anthrax

(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with Anthrax in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bozoukova, V; Hall, K; Hartikka, J; Kaslow, DC; Lalor, P; Leamy, V; Mahajan, RK; Martin, T; Rolland, A; Rusalov, D; Vilalta, A	1

Other Studies

1 other study(ies) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Anthrax

Article	Year
II. Cationic lipid-formulated plasmid DNA-based Bacillus anthracis vaccine: evaluation of plasmid DNA persistence and integration potential. Human gene therapy, 2005, Volume: 16, Issue:10 Topics: Animals; Anthrax; Anthrax Vaccines; Bacillus anthracis; Drug Evaluation, Preclinical; Humans; Injections, Intramuscular; Lipids; Muscle, Skeletal; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Rabbits; Vaccines, DNA	2005

Article

Year

II. Cationic lipid-formulated plasmid DNA-based Bacillus anthracis vaccine: evaluation of plasmid DNA persistence and integration potential.

Human gene therapy, 2005, Volume: 16, Issue:10

Topics: Animals; Anthrax; Anthrax Vaccines; Bacillus anthracis; Drug Evaluation, Preclinical; Humans; Injections, Intramuscular; Lipids; Muscle, Skeletal; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Rabbits; Vaccines, DNA

2005